Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Holcenberg

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Cancer Treatment Reports|June 1, 1979
Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginaseJ S Holcenberg
Northwest Medicine|November 1, 1970
Drug therapy. 8. Clinical application of the biologic half-life of drugsJ S Holcenberg
Northwest Medicine|April 1, 1971
Drug therapy. XII. Aspirin, what's new?J S Holcenberg
Cancer Treatment Reports|January 1, 1981
Enzyme therapy of cancer, future studiesJ S Holcenberg
Postgraduate Medicine|December 1, 1973
Treatment of overdose and withdrawal of abused drugsJ S Holcenberg
Methods in Enzymology|January 1, 1985
Glutaminase from Acinetobacter glutaminsificansJ S Holcenberg
Postgraduate Medicine|December 1, 1973
Editorial: Drug abuse--after acute management, supportive careJ S Holcenberg
Annual Review of Pharmacology and Toxicology|January 1, 1977
Enzymes as drugsJ S Holcenberg
Annual Review of Biochemistry|January 1, 1982
Enzyme therapy: problems and solutionsJ S Holcenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Effects of early leucovorin rescueJ S Holcenberg
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Cancer Treatment Reports|June 1, 1979
Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginaseJ S Holcenberg
Northwest Medicine|November 1, 1970
Drug therapy. 8. Clinical application of the biologic half-life of drugsJ S Holcenberg
Northwest Medicine|April 1, 1971
Drug therapy. XII. Aspirin, what's new?J S Holcenberg
Cancer Treatment Reports|January 1, 1981
Enzyme therapy of cancer, future studiesJ S Holcenberg
Postgraduate Medicine|December 1, 1973
Treatment of overdose and withdrawal of abused drugsJ S Holcenberg
Methods in Enzymology|January 1, 1985
Glutaminase from Acinetobacter glutaminsificansJ S Holcenberg
Postgraduate Medicine|December 1, 1973
Editorial: Drug abuse--after acute management, supportive careJ S Holcenberg
Annual Review of Pharmacology and Toxicology|January 1, 1977
Enzymes as drugsJ S Holcenberg
Annual Review of Biochemistry|January 1, 1982
Enzyme therapy: problems and solutionsJ S Holcenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Effects of early leucovorin rescueJ S Holcenberg
Pageof 9